INDIANAPOLIS, Jan. 21, 2016 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units ...

The US Food and Drug Administration approved a dedicated syringe for the administration of Humulin R U-500 insulin, which is now the only device approved for use with U-500 insulin vial. Humulin R ...

The FDA approved a dedicated syringe for the administration of Humulin R U-500 insulin, eliminating the need for dose conversions for patients who used U-100 or tuberculin syringes. The dedicated ...

Insulet To Develop New Version Of The OmniPod Insulin Pump For Use With Humulin R U-500 Concentrated Insulin For People With Type 2 Diabetes Bedford, MA (Marketwired) - Insulet Corporation (NASDAQ: ...

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company's (NYSE: LLY) Humulin ® R U-500 KwikPen ® (insulin human injection) 500 units/mL, a pre-filled device containing Humulin ...

The new device no longer requires dose conversions. The Food and Drug Administration (FDA) has approved a specific syringe for the administration of Humulin R U-500 (regular insulin [human, rDNA ...

Diabetes is a disease that causes high blood sugar levels. Not treating your high blood sugar levels can damage your heart and blood vessels. It can also lead to stroke, kidney failure, and blindness.

Eli Lilly announced the launch of Humulin R U-500 KwikPen (insulin human injection), a prefilled device containing a highly concentrated formulation of insulin. Eli Lilly announced the launch of ...

The active ingredient in Humulin N is isophane insulin human, which is a biologic. Humulin N belongs to a group of drugs called intermediate-acting insulins. Humulin N comes as a suspension (a type of ...

XP-3924 showed promising glucose control when compared to both Humulin® R and co-administered injections of Humulin® R and Symlin® XP-3924 was observed to be safe and well tolerated in this study ...